JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 15, 2007, 10.2967/jnumed.107.045310
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.045310v1
48/12/1981    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakayama, T.
Right arrow Articles by Tanaka, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakayama, T.
Right arrow Articles by Tanaka, K.
Journal of Nuclear Medicine Vol. 48 No. 12 1981-1986
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.045310

Clinical Investigation

Striatal D2 Receptor Availability After Shunting in Idiopathic Normal Pressure Hydrocephalus

Teiji Nakayama1, Yasuomi Ouchi2, Etsuji Yoshikawa3, Genichi Sugihara4, Tatsuo Torizuka2 and Keisei Tanaka1

1 Department of Neurosurgery, Hamamatsu Medical Center, Hamamatsu, Japan; 2 Positron Medical Center, Hamamatsu Medical Center, Hamamatsu, Japan; 3 Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan; and 4 Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan

Correspondence: For correspondence or reprints contact: Yasuomi Ouchi, MD, PhD, Human Imaging Research Laboratory, Molecular Imaging Frontier Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. E-mail: ouchi{at}pmc.hmedc.or.jp

Gait disturbance in idiopathic normal pressure hydrocephalus (iNPH) is reminiscent of parkinsonism. Our recent PET study showed reduction in postsynaptic D2 receptor binding concomitant with a normality of presynaptic dopamine transporter binding. Here, we investigated the plasticity of D2 receptor in treating iNPH patients with ventriculoperitoneal (VP) shunting using PET with 11C-raclopride and discuss the contribution of D2 receptor to the pathophysiology of iNPH. Methods: Eight iNPH patients participated in this study. After evaluation of their neuropsychologic abilities, all patients underwent 3-dimensional MRI and quantitative PET measurements twice before and 1 mo after VP shunting. MRI-based morphometric analyses were performed to examine postoperative variations of the ventricles. Estimation of binding potential (BP) for 11C-raclopride was based on Logan plot analysis. Region-of-interest analysis was used to examine changes in 11C-raclopride BP in the striatum. A 2-tailed paired t test was used for evaluating changes in PET and MRI parameters between conditions, and correlation analysis was used to investigate clinicopathophysiologic relevance (clinical vs. in vivo findings). Results: Clinical evaluation revealed significant recovery in a 5-m back-and-forth navigation test and an affect test and a mild increase in Mini-Mental State Examination scores after VP shunting. Significant postoperative increases in 11C-raclopride BP were found in the nucleus accumbens and dorsal putamen, and the increases were significantly associated with emotional (Spearman rank r = 0.66, P < 0.05) and navigational improvement (r = 0.72, P < 0.05), respectively. The 11C-raclopride BP increase in the striaum as a whole correlated significantly with improvement in general cognitive ability. There was a mild ventricular shrinkage after surgery, albeit there was no correlation of its size with clinical and PET parameters. Conclusion: Striatal upregulation of D2 receptor after VP shunting is associated with amelioration of hypokinetic gait disturbance and anhedonic mentation in iNPH patients, indicating that the effect of VP shunting may reside in noninhibition of functionally suppressed D2 receptor in the striatum. D2 receptor responsiveness may indicate a mechanism for iNPH pathophysiology.

Key Words: idiopathic normal pressure hydrocephalus • D2 receptor • raclopride • ventriculoperitoneal shunting • PET

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.